AU2002244968A1 - Anti-osteopontin antibody and use thereof - Google Patents
Anti-osteopontin antibody and use thereofInfo
- Publication number
- AU2002244968A1 AU2002244968A1 AU2002244968A AU2002244968A AU2002244968A1 AU 2002244968 A1 AU2002244968 A1 AU 2002244968A1 AU 2002244968 A AU2002244968 A AU 2002244968A AU 2002244968 A AU2002244968 A AU 2002244968A AU 2002244968 A1 AU2002244968 A1 AU 2002244968A1
- Authority
- AU
- Australia
- Prior art keywords
- osteopontin antibody
- osteopontin
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004965 antibodies Human genes 0.000 title 1
- 108090001123 antibodies Proteins 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-107578 | 2001-04-05 | ||
| JP2001107578 | 2001-04-05 | ||
| JP2001290700 | 2001-09-25 | ||
| JP2001-290700 | 2001-09-25 | ||
| PCT/JP2002/003382 WO2002081522A1 (en) | 2001-04-05 | 2002-04-04 | Anti-osteopontin antibody and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002244968A1 true AU2002244968A1 (en) | 2003-04-10 |
| AU2002244968B2 AU2002244968B2 (en) | 2007-07-26 |
Family
ID=26613159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002244968A Ceased AU2002244968B2 (en) | 2001-04-05 | 2002-04-04 | Anti-osteopontin antibody and use thereof |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20040234524A1 (en) |
| EP (2) | EP1375518B1 (en) |
| JP (1) | JP4230776B2 (en) |
| KR (1) | KR100881900B1 (en) |
| CN (1) | CN100469793C (en) |
| AR (1) | AR033121A1 (en) |
| AT (1) | ATE412013T1 (en) |
| AU (1) | AU2002244968B2 (en) |
| BR (1) | BR0208809A (en) |
| CA (1) | CA2443330A1 (en) |
| CZ (1) | CZ20032697A3 (en) |
| DE (1) | DE60229509D1 (en) |
| ES (1) | ES2314040T3 (en) |
| HU (1) | HUP0401561A2 (en) |
| MX (1) | MXPA03009052A (en) |
| NO (1) | NO20034405L (en) |
| NZ (1) | NZ528483A (en) |
| PL (1) | PL366469A1 (en) |
| RU (1) | RU2299888C2 (en) |
| WO (1) | WO2002081522A1 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002341488A1 (en) | 2001-05-09 | 2002-11-18 | Biovision Ag | Method for detecting progredient chronic dementia, and associated peptides and detection reagents |
| JP2005536439A (en) | 2001-09-18 | 2005-12-02 | ジェネンテック・インコーポレーテッド | Compositions and methods for tumor diagnosis and treatment |
| CN100352844C (en) | 2001-09-25 | 2007-12-05 | 财团法人化学及血清疗法研究所 | Recombinant anti-osteopontin antibody and use thereof |
| US7678889B2 (en) * | 2002-08-06 | 2010-03-16 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
| WO2004103403A1 (en) * | 2003-05-23 | 2004-12-02 | Immuno-Biological Laboratories Co., Ltd. | Immunocompetent cell activation inhibitor and use thereof |
| WO2005020785A2 (en) * | 2003-07-15 | 2005-03-10 | The Regents Of The University Of California | Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| CA2584028A1 (en) * | 2004-10-13 | 2006-04-27 | Genentech, Inc. | Method for treating tumors using anti-osteopontin antibodies |
| IN266863B (en) | 2005-01-13 | 2015-06-10 | Gene Techno Science Co Ltd | |
| KR20090024748A (en) | 2006-05-31 | 2009-03-09 | 아스텔라스세이야쿠 가부시키가이샤 | Humanized anti-human osteopontin antibody |
| AR061317A1 (en) | 2006-06-08 | 2008-08-20 | Chugai Pharmaceutical Co Ltd | AGENTS TO PREVENT OR TREAT INFLAMMATORY DISEASES |
| WO2007149948A2 (en) | 2006-06-20 | 2007-12-27 | The Gov. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for diagnosis and treatment of tumors |
| CA2657133C (en) | 2006-07-12 | 2017-04-11 | Gene Techno Science Co., Ltd. | Anti-human .alpha.9 integrin antibody and use of the same |
| US7981672B2 (en) | 2006-09-11 | 2011-07-19 | Immuno-Biological Laboratories Co., Ltd. | Monoclonal antibody and use thereof |
| WO2008050907A1 (en) * | 2006-10-26 | 2008-05-02 | Gene Techno Science Co., Ltd. | Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| CN101293916A (en) * | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof |
| CN101293924A (en) * | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments |
| KR100894265B1 (en) * | 2007-06-05 | 2009-04-21 | 재단법인서울대학교산학협력재단 | Injectable Bone Regeneration Gel containing Bone Formation Enhancing Peptide |
| JP2011501112A (en) | 2007-10-10 | 2011-01-06 | エフ．ホフマン−ラ ロシュ アーゲー | Means and methods for monitoring and treating myocardial infarction |
| BRPI0821110B8 (en) | 2007-12-05 | 2021-05-25 | Chugai Pharmaceutical Co Ltd | anti-nr10/il31ra neutralizing antibody, pharmaceutical composition comprising said antibody and use thereof |
| SI2243829T1 (en) | 2008-01-11 | 2014-11-28 | Astellas Pharma Inc. | IMPROVED HUMANIZED ANTI-HUMAN alpha9-INTEGRIN ANTIBODY |
| AU2009203350B2 (en) | 2008-01-11 | 2014-03-13 | Gene Techno Science Co., Ltd. | Humanized anti-alpha9 integrin antibodies and the uses thereof |
| AU2009238897B2 (en) * | 2008-04-24 | 2015-03-19 | Gene Techno Science Co., Ltd. | Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
| WO2010095270A1 (en) | 2009-02-23 | 2010-08-26 | 株式会社ジーンテクノサイエンス | Anti-human α9 integrin antibody and use thereof |
| KR101667227B1 (en) | 2009-03-10 | 2016-10-18 | 가부시키가이샤 진 테크노 사이언스 | Generation, expression and characterization of the humanized k33n monoclonal antibody |
| EP2431738A4 (en) * | 2009-05-12 | 2013-05-22 | Innopharmascreen Inc | Method for screening osteopontin inhibitor and inhibitor prepared thereby |
| CA2772230C (en) | 2009-09-24 | 2019-01-08 | Gene Techno Science Co., Ltd. | Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| RU2013141079A (en) | 2011-03-01 | 2015-04-10 | Ново Нордиск А/С | DR3 ANTAGONIC LIGANDS |
| GB2493540A (en) | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
| TW201623329A (en) * | 2014-06-30 | 2016-07-01 | 亞佛瑞司股份有限公司 | Vaccines and monoclonal antibodies targeting truncated variants of osteopontin and uses thereof |
| BR112017022101A2 (en) | 2015-04-14 | 2018-07-31 | Chugai Seiyaku Kabushiki Kaisha | pharmaceutical composition for prevention and / or treatment of atopic dermatitis containing il-31 antagonist as an active ingredient |
| US20220324956A1 (en) * | 2019-08-09 | 2022-10-13 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic Antibodies Against Osteopontin |
| AR120512A1 (en) | 2019-11-20 | 2022-02-16 | Chugai Pharmaceutical Co Ltd | FORMULATIONS CONTAINING ANTIBODIES |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US171358A (en) * | 1875-12-21 | Improvement in machines for trimming and punching roofing-slates | ||
| US63247A (en) * | 1867-03-26 | hbtdeick | ||
| US63241A (en) * | 1867-03-26 | Jacob green | ||
| US705842A (en) * | 1901-10-25 | 1902-07-29 | Daniel M Moroney | Machine for assembling links in making chain belts. |
| US5459060A (en) * | 1989-08-24 | 1995-10-17 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| GB9122820D0 (en) * | 1991-10-28 | 1991-12-11 | Wellcome Found | Stabilised antibodies |
| AU681633B2 (en) * | 1993-03-11 | 1997-09-04 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Anti-HIV monoclonal antibody |
| EP0705842A2 (en) * | 1994-10-06 | 1996-04-10 | Hoechst Aktiengesellschaft | Regulated genes by stimulation of chondrocytes with 1L-1beta |
| US6414219B1 (en) * | 1998-06-30 | 2002-07-02 | Rutgers, The State University Of New Jersey | Osteopontin knock-out mouse and methods of use thereof |
| JP2002543775A (en) * | 1999-04-15 | 2002-12-24 | チルドレンズ メディカル センター コーポレーション | Chemotactic and inhibitory drugs from osteopontin and uses thereof |
| DE60131525T2 (en) * | 2000-03-23 | 2008-09-25 | Glaxo Group Ltd., Greenford | PROCESS FOR SCREENING INHIBITORS FOR OSTEOPONTIN |
| CN100352844C (en) * | 2001-09-25 | 2007-12-05 | 财团法人化学及血清疗法研究所 | Recombinant anti-osteopontin antibody and use thereof |
-
2002
- 2002-04-04 CZ CZ20032697A patent/CZ20032697A3/en unknown
- 2002-04-04 NZ NZ528483A patent/NZ528483A/en unknown
- 2002-04-04 EP EP02713293A patent/EP1375518B1/en not_active Expired - Lifetime
- 2002-04-04 KR KR1020037012488A patent/KR100881900B1/en not_active IP Right Cessation
- 2002-04-04 WO PCT/JP2002/003382 patent/WO2002081522A1/en active IP Right Grant
- 2002-04-04 CA CA002443330A patent/CA2443330A1/en not_active Abandoned
- 2002-04-04 EP EP06120039A patent/EP1754719A3/en not_active Withdrawn
- 2002-04-04 JP JP2002579907A patent/JP4230776B2/en not_active Expired - Fee Related
- 2002-04-04 ES ES02713293T patent/ES2314040T3/en not_active Expired - Lifetime
- 2002-04-04 AT AT02713293T patent/ATE412013T1/en not_active IP Right Cessation
- 2002-04-04 RU RU2003132446/13A patent/RU2299888C2/en not_active IP Right Cessation
- 2002-04-04 AU AU2002244968A patent/AU2002244968B2/en not_active Ceased
- 2002-04-04 BR BR0208809-6A patent/BR0208809A/en not_active IP Right Cessation
- 2002-04-04 MX MXPA03009052A patent/MXPA03009052A/en active IP Right Grant
- 2002-04-04 HU HU0401561A patent/HUP0401561A2/en unknown
- 2002-04-04 PL PL02366469A patent/PL366469A1/en unknown
- 2002-04-04 CN CNB028110862A patent/CN100469793C/en not_active Expired - Fee Related
- 2002-04-04 US US10/473,134 patent/US20040234524A1/en not_active Abandoned
- 2002-04-04 DE DE60229509T patent/DE60229509D1/en not_active Expired - Lifetime
- 2002-04-05 AR ARP020101262A patent/AR033121A1/en not_active Application Discontinuation
-
2003
- 2003-10-02 NO NO20034405A patent/NO20034405L/en not_active Application Discontinuation
-
2007
- 2007-08-08 US US11/836,078 patent/US20080069815A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002244968A1 (en) | Anti-osteopontin antibody and use thereof | |
| AU2002332290A1 (en) | Recombinant anti-osteopontin antibody and use thereof | |
| EP1375518A4 (en) | Anti-osteopontin antibody and use thereof | |
| HK1084127A1 (en) | Recombinant anti-osteopontin antibody and use thereof | |
| AU2002251913A1 (en) | Hybrid antibodies and uses thereof | |
| AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| AU2002340167A1 (en) | Anti-hla-dr antibodies and the methods of using thereof | |
| AU2001256325A1 (en) | Human and humanized fap-alpha-specific antibodies | |
| AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
| AU2002365649A1 (en) | Anti-dota antibody | |
| AU2002365228A1 (en) | Antigen panels and methods of using the same | |
| AU2002343724A1 (en) | Adhesive and use thereof | |
| AU2003219093A1 (en) | Anti-hpv-16 e7 antibodies and their use | |
| EP1589033A4 (en) | Antibody and use thereof | |
| GB0122724D0 (en) | Trx1 antibody and uses therefor | |
| AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
| AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
| AU2001261534A1 (en) | The meca-79 antigen and related methods | |
| AU2001253852A1 (en) | Preprocalcitonin as tumor rejection antigen precursor and uses thereof | |
| AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
| AU2002251543A1 (en) | Novel atisane compound and use thereof | |
| AU2002338089A1 (en) | Antibody and use thereof | |
| EP1437367A4 (en) | Antibody and use thereof | |
| AU2002330299A1 (en) | Antibody and use of the same |